| COVID-19 Antibody Trials Have Begun #MMPMID32662848Abbasi JJAMA 2020[Jul]; 324 (2): 128 PMID32662848show ga
ä|Antibodies, Monoclonal/*therapeutic use[MESH]|Antibodies, Neutralizing/therapeutic use[MESH]|Antibodies, Viral/*therapeutic use[MESH]|Betacoronavirus[MESH]|COVID-19[MESH]|Clinical Trials, Phase I as Topic[MESH]|Coronavirus Infections/*therapy[MESH]|Humans[MESH]|Immunoglobulin G/therapeutic use[MESH]|Pandemics[MESH]|Pneumonia, Viral/*therapy[MESH]|Randomized Controlled Trials as Topic[MESH]
DeepDyve Pubget Overpricing |
|